MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making

NCT ID: NCT05299983

Last Updated: 2025-03-27

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

410 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-15

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As part of a National Institute on Aging -funded R01, the investigators developed an evidence-based, multi-media digital resource entitled MyMenoPlan to help women learn about the menopause transition, and the symptoms and treatments of perimenopause/menopause. MyMenoPlan is also designed to help women learn about the effectiveness of treatments for a comprehensive list of midlife symptoms and compare treatments that may help with the specific symptoms women are experiencing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this research study is to:

1. Investigate how women randomly assigned to visit MyMenoPlan use the website (time spent on website, treatment and symptom page views, use of interactive tools, and use of the MyMenoPlan tool).
2. Compare the ratings of women randomly assigned to MyMenoPlan to those randomly assigned to other menopause websites for perceived quality of information, readability, self-efficacy, and credibility of these online menopause resources.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopause Premenopause Postmenopause

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MyMenoPlan

Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.

Group Type EXPERIMENTAL

MyMenoPlan

Intervention Type OTHER

Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.

Control

Participants are asked to spend at least 20 minutes on at least one of the following websites or other websites of their choice:

1. North American Menopause Society: https://www.menopause.org/for-women
2. National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause
3. The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause

Group Type ACTIVE_COMPARATOR

Control

Intervention Type OTHER

Participants are asked to spend at least 20 minutes on at least one of the following websites:

1. North American Menopause Society: https://www.menopause.org/for-women
2. National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause
3. The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MyMenoPlan

Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.

Intervention Type OTHER

Control

Participants are asked to spend at least 20 minutes on at least one of the following websites:

1. North American Menopause Society: https://www.menopause.org/for-women
2. National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause
3. The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* As stated above

Exclusion Criteria

* N/A
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, San Diego

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrea Z. LaCroix, PhD

Distinguished Professor of Epidemiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrea Z. LaCroix, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, San Diego

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UC San Diego

La Jolla, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Snyder LB, Newton KM, Ng HX, Reed SD, Guthrie KA, Zambrano V, LaCroix AZ. Positive impact of a menopause website - MyMenoplan.org - on treatment intentions, knowledge, and decision making: A randomized controlled trial. Maturitas. 2025 Aug;199:108630. doi: 10.1016/j.maturitas.2025.108630. Epub 2025 Jun 5.

Reference Type DERIVED
PMID: 40505527 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

140604

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Menopausal HT for Women Living With HIV (HoT)
NCT06856174 NOT_YET_RECRUITING PHASE4
The Vaginal Health Trial
NCT02516202 COMPLETED PHASE3